1. Home
  2. CIG vs GKOS Comparison

CIG vs GKOS Comparison

Compare CIG & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comp En De Mn Cemig ADS

CIG

Comp En De Mn Cemig ADS

HOLD

Current Price

$2.05

Market Cap

5.8B

Sector

Utilities

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$108.99

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIG
GKOS
Founded
1952
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CIG
GKOS
Price
$2.05
$108.99
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$123.62
AVG Volume (30 Days)
2.9M
860.2K
Earning Date
03-19-2026
10-29-2025
Dividend Yield
10.85%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$7,960,960,695.00
$469,820,000.00
Revenue This Year
N/A
$31.15
Revenue Next Year
N/A
$24.15
P/E Ratio
$8.50
N/A
Revenue Growth
9.92
30.38
52 Week Low
$1.59
$73.16
52 Week High
$2.30
$163.71

Technical Indicators

Market Signals
Indicator
CIG
GKOS
Relative Strength Index (RSI) 47.19 70.89
Support Level $1.98 $105.88
Resistance Level $2.16 $110.87
Average True Range (ATR) 0.04 3.39
MACD -0.01 -0.04
Stochastic Oscillator 37.14 80.77

Price Performance

Historical Comparison
CIG
GKOS

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: